Sanara Medtech Inc

詳細情報 Sanara Medtech Inc 企業名

Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. It markets several products for surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products, CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus Advanced Viable Bone Matrix (ALLOCYTE Plus), BIASURGE, FORTIFY TRG Tissue Repair Graft (FORTIFY TRG), and FORTIFY FLOWABLE Extracellular Matrix (FORTIFY FLOWABLE) are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. CellerateRX Surgical products, TEXAGEN products, FORTIFY TRG and FORTIFY FLOWABLE are used in specialties, including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and others.

企業情報

企業コードSMTI

会社名Sanara Medtech Inc

上場日Apr 07, 1994

最高経営責任者「CEO」Mr. Suresh V. (Sam) Muppalla

従業員数141

証券種類Ordinary Share

決算期末Apr 07

本社所在地1200 Summit Avenue

都市FORT WORTH

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号76102

電話番号18175292300

ウェブサイトhttps://sanaramedtech.com/

企業コードSMTI

上場日Apr 07, 1994

最高経営責任者「CEO」Mr. Suresh V. (Sam) Muppalla

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Ronald T. (Ron) Nixon

Executive Chairman of the Board, Chief Executive Officer

64.04K

--

Mr. Seth D. Yon

President, Chief Commercial Officer

61.29K

-7.44%

Ms. Ann Beal Salamone

Director

22.70K

+14.12%

Ms. Sara N. Ortwein

Independent Director

20.80K

+18.70%

Mr. Eric D. Tanzberger

Independent Director

17.66K

+25.52%

Mr. Eric D. Major

Independent Director

9.39K

+53.64%

Mr. Keith G. Myers

Independent Director

4.94K

+150.13%

Mr. Suresh V. (Sam) Muppalla

President and Chief Executive Officer of Tissue Health Plus, LLC

2.97K

--

Mr. Jacob A. Waldrop

Chief Operating Officer

--

Mr. Roszell Mack, III

Independent Director

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Ronald T. (Ron) Nixon

Executive Chairman of the Board, Chief Executive Officer

64.04K

--

Mr. Seth D. Yon

President, Chief Commercial Officer

61.29K

-7.44%

Ms. Ann Beal Salamone

Director

22.70K

+14.12%

Ms. Sara N. Ortwein

Independent Director

20.80K

+18.70%

Mr. Eric D. Tanzberger

Independent Director

17.66K

+25.52%

Mr. Eric D. Major

Independent Director

9.39K

+53.64%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

事業別USD

会社名

収益

比率

Soft tissue repair products

20.53M

87.62%

Bone fusion products

2.90M

12.38%

データなし

事業別

地域別

事業別USD

会社名

収益

比率

Soft tissue repair products

20.53M

87.62%

Bone fusion products

2.90M

12.38%

株主

更新時刻: Thu, May 29

株主統計

種類

株主統計

比率

FA Sanara, L.L.C.

39.51%

Stuckert (James W)

10.88%

Tall Pines Capital LLC

5.77%

Howell (Solomon Oden Jr)

5.52%

The Vanguard Group, Inc.

2.21%

Other

36.11%

株主統計

比率

FA Sanara, L.L.C.

39.51%

Stuckert (James W)

10.88%

Tall Pines Capital LLC

5.77%

Howell (Solomon Oden Jr)

5.52%

The Vanguard Group, Inc.

2.21%

Other

36.11%

種類

株主統計

比率

Corporation

45.28%

Individual Investor

20.06%

Investment Advisor

6.63%

Investment Advisor/Hedge Fund

3.35%

Research Firm

0.77%

Hedge Fund

0.56%

Bank and Trust

0.12%

Pension Fund

0.11%

Insurance Company

0.02%

Other

23.09%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

125

6.84M

76.91%

+482.04K

2025Q1

128

6.77M

77.90%

+391.75K

2024Q4

125

6.79M

77.72%

+603.56K

2024Q3

120

6.67M

76.37%

+483.73K

2024Q2

117

5.99M

68.68%

-126.89K

2024Q1

114

5.90M

70.54%

-174.47K

2023Q4

113

5.89M

70.53%

-138.63K

2023Q3

112

5.89M

70.55%

-196.98K

2023Q2

105

5.91M

70.95%

+122.70K

2023Q1

75

5.66M

71.11%

-305.86K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

FA Sanara, L.L.C.

3.51M

39.51%

--

Apr 11, 2025

Stuckert (James W)

966.97K

10.88%

--

Apr 11, 2025

Tall Pines Capital LLC

512.87K

5.77%

+512.87K

--

Sep 30, 2024

Howell (Solomon Oden Jr)

490.39K

5.52%

--

Apr 11, 2025

The Vanguard Group, Inc.

196.47K

2.21%

-4.33K

-2.15%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

193.22K

2.17%

-3.99K

-2.02%

Mar 31, 2025

Stonebridge Wealth Management, LLC

100.06K

1.13%

+100.06K

--

Sep 30, 2024

Geode Capital Management, L.L.C.

88.75K

1%

+881.00

+1.00%

Mar 31, 2025

Nixon (Ronald T)

64.04K

0.72%

--

Apr 11, 2025

State Street Global Advisors (US)

63.28K

0.71%

-900.00

-1.40%

Mar 31, 2025

詳細を見る

24.490USD

Sanara Medtech Inc

24.490

概要

企業名

金融